| David Robert Braatz, MS | |
|
3855 Pleasant Hill Rd, Suite 280, Duluth, GA 30096-1407 | |
| (404) 297-4230 | |
| Not Available |
| Full Name | David Robert Braatz |
|---|---|
| Gender | Male |
| Speciality | Audiologist |
| Location | 3855 Pleasant Hill Rd, Duluth, Georgia |
| Accepts Medicare Assignments | Medicare enrolled and may accept medicare through third-party reassignment. May prescribe medicare part D drugs. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1730438920 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 231H00000X | Audiologist | AUD003665 (Georgia) | Primary |
| Provider Name | Ent Of Georgia, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1922046424 PECOS PAC ID: 1557254109 Enrollment ID: O20040206000068 |
News Archive
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
In 2004, 82 percent of adults and more than 50 percent of children took at least one prescription, over-the-counter (OTC), or herbal/natural medication in any given week, Boston University researchers revealed recently.
Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 2 days ago
| Provider Name | Piedmont Ear Nose &throat Associates Pc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1245305879 PECOS PAC ID: 8527024124 Enrollment ID: O20050104000298 |
News Archive
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
In 2004, 82 percent of adults and more than 50 percent of children took at least one prescription, over-the-counter (OTC), or herbal/natural medication in any given week, Boston University researchers revealed recently.
Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 2 days ago
| Provider Name | Gwinnett Physician Group, Llc |
|---|---|
| Provider Type | Part B Supplier - Clinic/group Practice |
| Provider Identifiers | NPI Number: 1578574661 PECOS PAC ID: 9133211139 Enrollment ID: O20070822001035 |
News Archive
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
In 2004, 82 percent of adults and more than 50 percent of children took at least one prescription, over-the-counter (OTC), or herbal/natural medication in any given week, Boston University researchers revealed recently.
Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 2 days ago
| Mailing Address | Practice Location Address |
|---|---|
| David Robert Braatz, MS 4380 Georgetown Sq, Suite 1002, Atlanta, GA 30338-6254 Ph: (770) 220-8400 | David Robert Braatz, MS 3855 Pleasant Hill Rd, Suite 280, Duluth, GA 30096-1407 Ph: (404) 297-4230 |
News Archive
A decline in contributions from the WHO's leading 30 "traditional" donor nations and the exchange rate for the weaker U.S. dollar are causing the agency to cut its budget and staff, WHO Director-General Margaret Chan told reporters in a news conference at the World Health Assembly in Geneva on Tuesday, the Associated Press reports.
In 2004, 82 percent of adults and more than 50 percent of children took at least one prescription, over-the-counter (OTC), or herbal/natural medication in any given week, Boston University researchers revealed recently.
Researchers at the MRC Integrative Epidemiology Unit (IEU), Bristol Medical School, University of Bristol, Bristol, UK, found that carnitine and its derivative acetyl-carnitine provide a protective effect against severe COVID-19. Doubling of carnitine or acetyl-carnitine is tied to a 40-percent reduction risk of disease progression.
AVEO Pharmaceuticals, Inc. today announced the initiation of patient enrollment in an open-label, multicenter, randomized Phase 2 clinical trial, called BATON-CRC, evaluating tivozanib in combination with modified FOLFOX6 (mFOLFOX6) compared to bevacizumab in combination with mFOLFOX6 as first-line therapy in patients with advanced metastatic colorectal cancer.
› Verified 2 days ago
Erin Archer, AUD Audiologist Medicare: Medicare Enrolled Practice Location: 3650 Steve Reynolds Blvd, Duluth, GA 30096 Phone: 800-611-1811 | |
Dr. Sara Martin Woolley, AU.D. Audiologist Medicare: Accepting Medicare Assignments Practice Location: 6600 Sugarloaf Pkwy, Suite 800, Duluth, GA 30097 Phone: 770-476-3005 Fax: 770-476-0053 | |
Audiological Consultants Of Atlanta, Inc. Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6600 Sugarloaf Pkwy, Suite 800, Duluth, GA 30097 Phone: 770-476-3005 | |
Katrina Goddard Williams, M.S., LIC-A Audiologist Medicare: Not Enrolled in Medicare Practice Location: 6630 Mcginnis Ferry Rd, Suite B, Duluth, GA 30097 Phone: 404-297-4230 Fax: 770-232-0847 |